RZLT
Rezolute IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$312.95M
P/E Ratio
—
EPS
$-0.81
Beta
0.67
52W High
$11.46
52W Low
$1.07
50-Day MA
$3.15
200-Day MA
$5.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Rezolute Inc
Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-85.82M |
| Operating Margin | 0.00% |
| Return on Equity | -81.70% |
| Return on Assets | -48.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.23 |
| Price-to-Book | 2.69 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $96.29M |
| Float | $66.03M |
| % Insiders | 10.18% |
| % Institutions | 90.26% |
Historical Volatility
HV 10-Day
50.18%
HV 20-Day
57.12%
HV 30-Day
52.58%
HV 60-Day
78.06%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.88 target)
1
Strong Buy6
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026